These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 11069385)

  • 61. Efficacy and acceptance of the sacral neuromodulation in the treatment of female lower urinary tract dysfunctions.
    Adile B; Speciale P; Gugliotta G; Consiglio P; Manzone M; Adile G; Saitta S; Perino A; Calagna G
    Minerva Ginecol; 2018 Apr; 70(2):236-238. PubMed ID: 29083137
    [No Abstract]   [Full Text] [Related]  

  • 62. Changes in brain activity following sacral neuromodulation for urinary retention.
    Dasgupta R; Critchley HD; Dolan RJ; Fowler CJ
    J Urol; 2005 Dec; 174(6):2268-72. PubMed ID: 16280802
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Bladder stones following SCI in the Sprague-Dawley rat.
    Linsenmeyer TA; Ottenweller J
    J Spinal Cord Med; 2003; 26(1):65-8. PubMed ID: 12830972
    [TBL] [Abstract][Full Text] [Related]  

  • 64. [Effect of electroacupuncture of different acupoints on the excitability of detrusor muscle and the expression of BDNF and TrkB in the spinal cord of rats with urinary retention due to spinal cord injury].
    Wang JH; Chen BG; Yin J; Wang G; Zou WG; Luo XJ
    Zhen Ci Yan Jiu; 2009 Dec; 34(6):387-92. PubMed ID: 20209974
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Sacral neuromodulation for treating the symptoms of overactive bladder syndrome and non-obstructive urinary retention: >10 years of clinical experience.
    Chartier-Kastler E
    BJU Int; 2008 Feb; 101(4):417-23. PubMed ID: 18070181
    [No Abstract]   [Full Text] [Related]  

  • 66. Sacral Neuromodulation for Refractory Bladder Pain Syndrome/Interstitial Cystitis: a Global Systematic Review and Meta-analysis.
    Wang J; Chen Y; Chen J; Zhang G; Wu P
    Sci Rep; 2017 Sep; 7(1):11031. PubMed ID: 28887515
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Type 4 phosphodiesterase inhibitor suppresses experimental bladder inflammation.
    Kitta T; Tanaka H; Mitsui T; Moriya K; Nonomura K
    BJU Int; 2008 Nov; 102(10):1472-6. PubMed ID: 18410434
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Reduction of oxidative stress may play a role in the anti-inflammatory effect of the novel herbal formulation in a rat model of hydrochloric acid-induced cystitis.
    Bae WJ; Ha US; Kim S; Kim SJ; Hong SH; Lee JY; Hwang TK; Hwang SY; Kim HJ; Kim SW
    Neurourol Urodyn; 2015 Jan; 34(1):86-91. PubMed ID: 24151066
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Re: Percutaneous sacral nerve root neuromodulation for intractable interstitial cystitis.
    Chai TC
    J Urol; 2001 Sep; 166(3):1009. PubMed ID: 11490282
    [No Abstract]   [Full Text] [Related]  

  • 70. Sacral neuromodulation for urinary retention.
    Kessler TM; Fowler CJ
    Nat Clin Pract Urol; 2008 Dec; 5(12):657-66. PubMed ID: 19002127
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Combination of sacral nerve and tibial nerve stimulation for treatment of bladder overactivity in pigs.
    Li X; Liao L; Chen G; Wang Z; Deng H
    Int Urol Nephrol; 2017 Jul; 49(7):1139-1145. PubMed ID: 28421392
    [TBL] [Abstract][Full Text] [Related]  

  • 72. [Experimental studies on microcirculatory inflammatory reactions of the urinary bladder].
    Járomi P; Szabó A; Garab D; Bodnár D; Uhercsák G; Boros M; Hartmann P
    Magy Seb; 2012 Aug; 65(4):184-90. PubMed ID: 22940386
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Increased expression of growth-associated protein (GAP-43) in lower urinary tract pathways following cyclophosphamide (CYP)-induced cystitis.
    Vizzard MA; Boyle MM
    Brain Res; 1999 Oct; 844(1-2):174-87. PubMed ID: 10536274
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Sacral nerve neuromodulation (InterStim). Part I: Review of the InterStim system.
    Rittenmeyer H
    Urol Nurs; 2008 Feb; 28(1):15-20. PubMed ID: 18335692
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Cyclophosphamide cystitis as a model of visceral pain in rats: model elaboration and spinal structures involved as revealed by the expression of c-Fos and Krox-24 proteins.
    Lantéri-Minet M; Bon K; de Pommery J; Michiels JF; Menétrey D
    Exp Brain Res; 1995; 105(2):220-32. PubMed ID: 7498375
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Tibial nerve stimulation diminishes mast cell infiltration in the bladder wall induced by interstitial cystitis urine.
    Danisman A; Kutlu O; Akkaya E; Karpuzoğlu G; Erdoğru T
    Scand J Urol Nephrol; 2007; 41(2):98-102. PubMed ID: 17454946
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Secondary changes in bowel function after successful treatment of voiding symptoms with neuromodulation.
    Killinger KA; Kangas JR; Wolfert C; Boura JA; Peters KM
    Neurourol Urodyn; 2011 Jan; 30(1):133-7. PubMed ID: 20928914
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Urinary retention after hysterectomy: sacral neuromodulation to restore micturition.
    von Heyden B; Bothe HW; Hertle L
    J Urol; 1999 Dec; 162(6):2094-5. PubMed ID: 10569582
    [No Abstract]   [Full Text] [Related]  

  • 79. Editorial Comment to Sacral neuromodulation is an effective option for non-obstructive urinary retention in men with cerebral palsy.
    Yamamoto T; Gotoh M
    Int J Urol; 2014 Apr; 21(4):431. PubMed ID: 24812688
    [No Abstract]   [Full Text] [Related]  

  • 80. Sacral neuromodulation in functional urinary retention: an effective way to restore voiding.
    Wiseman OJ; Dasgupta R; Fowler CJ
    BJU Int; 2003 Apr; 91(6):583. PubMed ID: 12656923
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.